SYNAPTYS neuroscience is developing SYS-0108, an innovative combinatorial therapy designed to act simultaneously on several key mechanisms involved in Alzheimer’s disease.

Our conviction is rooted in a simple scientific principle:
👉 Alzheimer’s is multifactorial — its treatment must be as well.

Our goal is to provide a new therapeutic option capable of altering the trajectory of the disease and sustainably improving the lives of patients and their families.

With a new case of dementia diagnosed every 3 seconds, the urgency to innovate has never been greater.

SYS-0108 is now progressing toward decisive milestones in its preclinical development, supported by rigorous scientific strategy, high-level academic collaborations, and a solid intellectual property framework.

SYNAPTYS neuroscience

Org chart

Teams

Offices